Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Applications
Proteomics Services In Europe
11 services found
Manufactured by:Cambridge Protein Arrays Ltd. (CPAP) based inCambridge, UNITED KINGDOM
Antibody validation, autoantibody target discovery, protein interaction screening and more on HuProt ...
Manufactured by:Tethis S.p.A based inMilan, ITALY
A complete analytical evaluation of morphological, proteomic and genetic features is possible at single cell level or on cell-free content. All the traditional biopsies’ techniques, such as cytology, immunocytochemistry, immunofluorescence, FISH and molecular analysis can be performed. ...
by:James Hutton Limited based inDundee, UNITED KINGDOM
The rapid development of –omics technologies, including genomics, transcriptomics, proteomics and metabolomics means that big data is at the heart of new discoveries in plant genetics and plant pathology. Bioinformatics is an interdisciplinary field that involves the development and application of computational methods for the analysis of large-scale biological data ...
by:PharmAI GmbH based inDresden, GERMANY
Increase your success rate at an early stage. With pharmAI's rapid off-target prediction service you can already find potential off-targets during the discovery ...
by:Indivumed GmbH based inHamburg, GERMANY
IndivuType uses our highest quality biospecimens and clinical data, combined with leading-edge analytical methods, to offer a unique multi-omics database. Thus, providing new insights into the biology of cancer and enabling new discoveries in the postgenomic ...
by:Indivumed GmbH based inHamburg, GERMANY
Once a target is identified the various effects of the drug can be measured. This involves all read-outs we use during the biomarker validation but instead of looking at the effect of various candidates we focus on one component. As the tumor microenvironment can play an important role we focus especially on test methods involving fresh tissue. ...
by:Indivumed GmbH based inHamburg, GERMANY
Cancer immunology, or “immuno-oncology,” is a growing field of research that aims to discover innovative cancer immunotherapies to treat and impede the progression of the disease. Understanding how cancer evades the immune system is the basis of immuno-oncology. With Indivumed’s scientific support you can, for example, identify the different types of immune cells and their ...
Manufactured by:CENTOGENE N.V. based inRostock, GERMANY
We work with partners to develop new disease models and new biomarkers of disease. We can also use our disease models to identify new drug targets and screen chemical compounds to identify potential new drug candidates. CENTOGENE provides companies with tools to accelerate drug discovery. From population screening studies that elucidate the prevalence of a rare disease to disease modeling, we are ...
by:Cmbio based inCopenhagen, DENMARK
Unlock deeper insights into microbial communities with our specialized Long-Read Metagenomics services. Utilizing long-read sequencing with Oxford Nanopore Technologies (ONT), we provide highly contiguous assemblies and high-quality metagenome-assembled genomes (MAGs) from complex samples such as soil, wastewater, and gastrointestinal ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Veracyte’s Cancer Immune Atlas allows clinical researchers to maximize the value of the data generated through our Immunogram analysis platform. The Cancer Immune Atlas creates a reference database from individual Immunograms, to generate biomarker maps, assess toxicity and drug response, stratify patients, and develop predictive ...
by:Cmbio based inCopenhagen, DENMARK
The gut microbiome is central to digestive health and metabolic processes, influencing conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and metabolic disorders like obesity and diabetes. At Cmbio, we offer multi-omics solutions to explore the connections between the gut microbiome, digestion, and metabolism. Our tools provide actionable insights to drive ...